More and more public chains are beginning to develop vertically.

Therefore, it's no longer accurate to evaluate public chains solely by TVL as we did before. We should pay more attention to trading volume, order book depth, and fee turnover speed.

This also explains why some chains have relatively low TVL metrics but high trading activity, such as @injective.

Injective positions itself as a Layer-1 blockchain. What makes it unique is that it packages on-chain order books, MultiVM architecture, and zero gas costs together, focusing on the DeFi and RWA sectors—two tracks that require the highest performance and compliance.

After Injective's native EVM mainnet goes live in November 2025, both EVM and WASM virtual machines will be able to develop simultaneously, significantly lowering the barrier for developers and allowing more DEXs, structured products, and RWA protocols to migrate seamlessly.

As the core DEX of the ecosystem, @Helix has already delivered results: 24/5 real-time stock trading is live, and RWA perpetual contracts have accumulated over $6 billion in trading volume, all indicating that Injective is pursuing the route of "enabling blockchains to directly support traditional financial scenarios."

The background strength is also impressive, with investors like Jump Crypto, Pantera Capital, and YZi Labs participating in $56.2M in funding. Looking forward to seeing it carve out differentiated competitiveness in the future DeFi and RWA tracks.

$INJ #Injective